To see this page, please, enable javaScript and styleSheets on your browser: Tools -> Internet Options ...
Reload !
Gene SNRPB2TABLE OF CONTENTS / OPEN CLOSE ALL PARAGRAPHS
Summary back to top
Compact gene diagram back to top
476 supporting clones for gene SNRPB2 back to top
cDNA accession
Links to the sequence
Tissue

most 5' clones
in red
Match
mRNA
From bp
to bp
in mRNA
From bp
to bp
in accs.
Clone encodes
complete protein
(with AA variation)
Features Anomalies
detected by
AceView
Accession
match over
(% length)
Base differences
relative to genome
(% identity)
NM_003092.4   .a 1 to 1680 2 to 1681 exact RefSeq, AAA Possibly primed on the genome, locally A rich (24/25 A in genome downstream of last aligned base) 1681/1681
(100 %)
0 diff
(100 %id)
BF243328 bone marrow, from acute myelogenous leukemia .a 19 to 597 1 to 573   tiling clone,   573/848
(67 %)
31 diff
(96.4 %id)
TI_44345455   .a 24 to 869 79 to 919       841/919
(91 %)
20 diff
(97.9 %id)
BI670500 brain, hypothalamus .a 30 to 869 5 to 840       836/840
(99 %)
20 diff
(97.7 %id)
BI669862 brain, hypothalamus .a 34 to 788 1 to 757       757/757
(100 %)
8 diff
(99.0 %id)
TI_44344396   .a 39 to 788 87 to 838       752/838
(89 %)
10 diff
(98.9 %id)
BF541438 hypernephroma, Kidney .a 40 to 617 1 to 585       585/850
(68 %)
36 diff
(95.8 %id)
AU310686 neuroblastoma .a 40 to 629 10 to 599   fully sequenced, Possibly primed on the genome, locally A rich (24/25 A in genome downstream of last aligned base) 590/599
(98 %)
6 diff
(99.0 %id)
BF665929 brain, primitive neuroectoderm .a 43 to 742 1 to 701       700/815
(85 %)
30 diff
(96.4 %id)
BF667231 brain, primitive neuroectoderm .a 47 to 673 1 to 621       621/624
(99 %)
17 diff
(97.3 %id)
BC018022 Brain, primitive neuroectodermal .a 48 to 1126 1 to 1079 exact available from MGC, AAA Possibly primed on the genome, locally A rich (24/25 A in genome downstream of last aligned base) 1079/1080
(99 %)
1 diff
(100.0 %id)
BF212437 bone marrow, from chronic myelogenous leukemia .a 52 to 602 1 to 548       548/590
(92 %)
11 diff
(98.2 %id)
BG537458 lung .a 52 to 558 1 to 514       514/636
(80 %)
14 diff
(97.8 %id)
TI_57202586   .a 56 to 906 62 to 920       859/928
(92 %)
29 diff
(96.9 %id)
CA397372 eye, RPE/choroid .a 57 to 678 1 to 622       622/622
(100 %)
1 diff
(99.9 %id)
BF028813 bladder, carcinoma, cell line .a 57 to 726 1 to 661       663/813
(81 %)
43 diff
(94.8 %id)
TI_44184996   .a 57 to 682 23 to 649       627/649
(96 %)
7 diff
(99.0 %id)
EC572189 Prostate .a 59 to 162 1 to 102       102/105
(97 %)
7 diff
(93.4 %id)
BF208385 bladder, carcinoma, cell line .a 60 to 581 1 to 521   AAA   521/524
(99 %)
26 diff
(95.1 %id)
DA372744 thalamus .a 61 to 605 2 to 546   capped   545/545
(100 %)
0 diff
(100 %id)
BF211040 bone marrow, from chronic myelogenous leukemia .a 61 to 543 1 to 485       485/757
(64 %)
9 diff
(98.9 %id)
CF597123 ovary .a 61 to 755 1 to 707       707/777
(90 %)
33 diff
(95.8 %id)
BF698360 brain, primitive neuroectoderm .a 62 to 739 1 to 670       670/885
(75 %)
33 diff
(96.3 %id)
BG542918 lung .a 62 to 735 1 to 680       680/710
(95 %)
27 diff
(96.2 %id)
BU567068 mixed (pool of 40 RNAs) .a 62 to 533 1 to 471       471/507
(92 %)
5 diff
(99.1 %id)
CD522722 pooled .a 62 to 755 1 to 695       695/857
(81 %)
11 diff
(98.8 %id)
AV759569 bone marrow .a 62 to 586 1 to 518       518/521
(99 %)
7 diff
(98.7 %id)
BM821407 stomach .a 62 to 542 1 to 481       481/481
(100 %)
0 diff
(100 %id)
BI823585 pooled brain, lung, testis .a 63 to 906 1 to 852       852/860
(99 %)
24 diff
(97.3 %id)
BI522437 brain .a 63 to 682 1 to 621       621/621
(100 %)
1 diff
(99.9 %id)
BI919223 brain .a 63 to 755 44 to 748       705/863
(81 %)
23 diff
(97.4 %id)
CB963603 Blood vessels - aorta, basilar and artery .a 63 to 666 1 to 605       605/780
(77 %)
6 diff
(99.3 %id)
TI_57239384   .a 63 to 755 44 to 748       705/863
(81 %)
23 diff
(97.4 %id)
BM758808 myeloma .a 63 to 497 1 to 435       435/435
(100 %)
0 diff
(100 %id)
BG942181 blood .a 64 to 182 1 to 119       119/119
(100 %)
1 diff
(99.2 %id)
DA365963 subthalamic nucleus .a 64 to 617 13 to 566   capped   554/556
(99 %)
6 diff
(99.0 %id)
CR595063 adult brain .a 64 to 1583 1 to 1520 exact tiling clone,   1520/1520
(100 %)
0 diff
(100 %id)
BX444346 adult brain, brain .a 64 to 724 1 to 660   fully sequenced,   660/660
(100 %)
1 diff
(99.9 %id)
DN915197   .a 64 to 664 1 to 598       598/602
(99 %)
7 diff
(98.9 %id)
BF694464 muscle (skeletal) .a 64 to 617 1 to 552       550/854
(64 %)
28 diff
(96.8 %id)
BF668040 brain, primitive neuroectoderm .a 64 to 617 1 to 555       555/876
(63 %)
21 diff
(97.7 %id)
BG530698 embryonal carcinoma, testis .a 64 to 789 1 to 730       730/732
(99 %)
20 diff
(97.3 %id)
BG533726 Liver .a 64 to 618 1 to 564       564/791
(71 %)
26 diff
(96.8 %id)
BG776571 lung, mucoepidermoid carcinoma .a 64 to 825 1 to 763       763/763
(100 %)
11 diff
(98.6 %id)
BG777124 lung, mucoepidermoid carcinoma .a 64 to 897 1 to 834       834/834
(100 %)
30 diff
(96.5 %id)
BP203240 coronary artery .a 65 to 639 1 to 575       575/575
(100 %)
3 diff
(99.5 %id)
BP213870 cerebrum .a 65 to 553 1 to 489   AAA   489/490
(99 %)
4 diff
(99.2 %id)
CD689922 normal nasopharynx .a 65 to 567 21 to 524       502/524
(95 %)
7 diff
(98.7 %id)
BU660645 blood .a 65 to 746 11 to 693       683/693
(98 %)
7 diff
(99.0 %id)
BF239046 bone marrow, from chronic myelogenous leukemia .a 65 to 706 1 to 641       641/907
(70 %)
37 diff
(96.0 %id)
BG493786 lung, mucoepidermoid carcinoma .a 65 to 530 1 to 466       466/466
(100 %)
2 diff
(99.6 %id)
BG528233 lung, mucoepidermoid carcinoma .a 65 to 584 1 to 517   AAA   517/517
(100 %)
8 diff
(98.5 %id)
BG539516 lung .a 65 to 745 1 to 679       679/917
(74 %)
31 diff
(96.7 %id)
BG687591 lung, mucoepidermoid carcinoma .a 65 to 678 1 to 614       614/614
(100 %)
2 diff
(99.7 %id)
AK313004 cerebellum .a 66 to 913 1 to 848 exact     848/848
(100 %)
0 diff
(100 %id)
DA277556 corpus callosum .a 66 to 629 2 to 564   capped   563/563
(100 %)
1 diff
(99.9 %id)
FN102878 breast carcinoma .a 66 to 154 13 to 102       90/102
(88 %)
6 diff
(94.2 %id)
DA607940   .a 66 to 696 2 to 631   capped   630/633
(99 %)
2 diff
(99.7 %id)
BP304827   .a 66 to 566 1 to 499       499/502
(99 %)
5 diff
(99.1 %id)
BP354415   .a 66 to 646 1 to 581       581/581
(100 %)
0 diff
(100 %id)
DB015730 esophageal, tumor tissue .a 66 to 644 2 to 581   capped   580/580
(100 %)
3 diff
(99.5 %id)
DA077000 cerebellum .a 67 to 635 2 to 570   capped   569/569
(100 %)
0 diff
(100 %id)
DA258923 caudate nucleus .a 67 to 617 2 to 552   capped   551/556
(99 %)
2 diff
(99.7 %id)
DA369133 subthalamic nucleus .a 67 to 637 2 to 573   capped   572/572
(100 %)
1 diff
(99.9 %id)
BU588321 mixed (pool of 40 RNAs) .a 68 to 475 1 to 408       408/1129
(36 %)
11 diff
(99.1 %id)
BU933046 mixed (pool of 40 RNAs) .a 68 to 882 1 to 818       818/820
(99 %)
15 diff
(98.2 %id)
BM906628 ovary (pool of 3) .a 69 to 1117 1 to 1063 exact     1063/1114
(95 %)
35 diff
(96.9 %id)
BQ438549 testis .a 69 to 539 1 to 472       472/503
(93 %)
7 diff
(98.7 %id)
BU536082 mixed (pool of 40 RNAs) .a 69 to 566 1 to 499       499/502
(99 %)
14 diff
(97.3 %id)
BF979210 melanotic melanoma, high MDR, skin .a 70 to 763 1 to 688       688/710
(96 %)
15 diff
(97.9 %id)
BG616322 embryonal carcinoma, testis .a 70 to 748 1 to 690       589/855
(68 %)
32 diff
(96.3 %id)
BG615466 embryonal carcinoma, testis .a 70 to 675 1 to 618       618/732
(84 %)
39 diff
(94.7 %id)
CA944527 Human Lung Epithelial cells, lung .a 71 to 565 16 to 510     Submitted on the opposite strand 495/513
(96 %)
3 diff
(99.5 %id)
BP380141 uterus .a 71 to 628 1 to 558       558/558
(100 %)
0 diff
(100 %id)
BP231950 muscle .a 72 to 551 1 to 480       480/487
(98 %)
2 diff
(99.6 %id)
BU927859 mixed (pool of 40 RNAs) .a 72 to 565 1 to 493       493/499
(98 %)
11 diff
(97.8 %id)
CB963628 Blood vessels - aorta, basilar and artery .a 72 to 510 1 to 439       439/440
(99 %)
3 diff
(99.4 %id)
DA897847 skeletal muscle .a 73 to 634 2 to 564   capped   563/563
(100 %)
3 diff
(99.5 %id)
BU954709 mixed (pool of 40 RNAs) .a 75 to 532 1 to 458       458/458
(100 %)
5 diff
(99.0 %id)
CB963784 Blood vessels - aorta, basilar and artery .a 75 to 754 1 to 685       685/737
(92 %)
9 diff
(98.8 %id)
DA606820   .a 76 to 632 2 to 558   capped   557/557
(100 %)
1 diff
(99.9 %id)
DA879300 Prostate .a 76 to 647 2 to 573   capped   572/572
(100 %)
0 diff
(100 %id)
BG503127 embryonal carcinoma, testis .a 77 to 784 1 to 703       703/706
(99 %)
16 diff
(97.8 %id)
BG534890 lung .a 77 to 779 1 to 701       701/703
(99 %)
12 diff
(98.3 %id)
BG575779 breast, mammary adenocarcinoma, cell line .a 78 to 903 1 to 827       827/828
(99 %)
8 diff
(99.1 %id)
BI668700 brain, hypothalamus .a 78 to 711 1 to 635       635/635
(100 %)
5 diff
(99.3 %id)
BF339754 brain, glioblastoma with EGFR amplification .a 79 to 752 13 to 689       677/1070
(63 %)
11 diff
(99.0 %id)
BI837493 pooled pancreas and spleen .a 79 to 814 1 to 746       746/851
(87 %)
20 diff
(97.7 %id)
BI860761 breast, mammary adenocarcinoma, cell line .a 79 to 823 1 to 751       751/828
(90 %)
20 diff
(97.6 %id)
CD105135 Pooled-Skin .a 79 to 546 1 to 468       468/784
(59 %)
4 diff
(99.5 %id)
TI_57165705   .a 79 to 814 30 to 775       746/880
(84 %)
22 diff
(97.5 %id)
TI_57192339   .a 79 to 823 48 to 798       751/828
(90 %)
20 diff
(97.6 %id)
DB461871 testis .a 80 to 549 1 to 474       470/474
(99 %)
0 diff
(100 %id)
BI862370 breast, mammary adenocarcinoma, cell line .a 80 to 899 1 to 824       824/838
(98 %)
21 diff
(97.5 %id)
CA455279 mixed (pool of 40 RNAs) .a 80 to 538 1 to 459       459/460
(99 %)
5 diff
(99.0 %id)
TI_57191605   .a 80 to 899 73 to 896       824/838
(98 %)
21 diff
(97.5 %id)
CN272677 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .a 82 to 703 1 to 622       622/622
(100 %)
2 diff
(99.7 %id)
BG504733 embryonal carcinoma, testis .a 82 to 730 1 to 650       650/651
(99 %)
8 diff
(98.8 %id)
BG527908 lung, mucoepidermoid carcinoma .a 82 to 754 1 to 670       670/861
(77 %)
22 diff
(97.5 %id)
BG778935 adenocarcinoma, Prostate .a 82 to 964 1 to 870 A110S K111Q T112N V113C E114G ... available from MGC,   868/884
(98 %)
26 diff
(97.1 %id)
CA337676 1st pharyngeal arch (pooled) .a 82 to 534 1 to 452       452/452
(100 %)
2 diff
(99.6 %id)
BC022311 Prostate, adenocarcinoma. .a 83 to 1101 1 to 1020 A110S K111Q T112N V113C E114G ... available from MGC, AAA Possibly primed on the genome, locally A rich (24/25 A in genome downstream of last aligned base) 1020/1020
(100 %)
1 diff
(100.0 %id)
BQ433851 embryonal carcinoma, cell line, testis .a 83 to 953 1 to 871 E179K V180Y R181V L182W V183Y ...     871/877
(99 %)
7 diff
(99.3 %id)
TI_44344136   .a 83 to 711 91 to 720       630/720
(87 %)
7 diff
(99.1 %id)
BM845436 lymph node, stomach .a 83 to 586 1 to 503       503/503
(100 %)
1 diff
(99.9 %id)
CR612578 fetal liver .a 84 to 1095 1 to 1012 exact     1012/1012
(100 %)
0 diff
(100 %id)
CR616888 B cells (Ramos cell line) Cot 25-normalized .a 84 to 1030 1 to 947 exact     947/947
(100 %)
0 diff
(100 %id)
CR620323 HeLa cells Cot 25-normalized .a 84 to 1121 1 to 1038 exact     1038/1038
(100 %)
0 diff
(100 %id)
BX384686   .a 84 to 882 1 to 799       799/882
(90 %)
10 diff
(98.9 %id)
BX343278   .a 84 to 1022 1 to 933 P184Q R186G H187M D188T I189L ...     933/941
(99 %)
40 diff
(95.8 %id)
DB527291 testis .a 84 to 544 1 to 465     Submitted on the opposite strand 461/465
(99 %)
0 diff
(100 %id)
BG680181 skin, squamous cell carcinoma .a 84 to 965 1 to 888 F98X K104N E106Q K107T A110K ...     888/928
(95 %)
28 diff
(97.0 %id)
DB142314 thymus .a 84 to 595 2 to 513   capped   512/512
(100 %)
0 diff
(100 %id)
CR592596 Neuroblastoma Cot 25-normalized .a 85 to 1087 1 to 1003 exact     1003/1003
(100 %)
0 diff
(100 %id)
BX354598 Neuroblastoma Cot 25-normalized .a 85 to 1115 1 to 1028 Q173X P184X R186E H187A D188* fully sequenced,   1028/1028
(100 %)
26 diff
(97.5 %id)
BE564364 bladder, carcinoma, cell line .a 85 to 755 1 to 676       676/813
(83 %)
26 diff
(96.9 %id)
BE620174 large cell carcinoma, undifferentiated, lung .a 85 to 763 1 to 671       671/901
(74 %)
27 diff
(97.1 %id)
BF132545 lung, mucoepidermoid carcinoma .a 86 to 752 1 to 665       662/708
(93 %)
25 diff
(96.5 %id)
BF795280 lymph, lymphoma, cell line .a 87 to 830 9 to 754       744/985
(75 %)
23 diff
(97.7 %id)
BI752970 brain .a 87 to 788 1 to 700       700/700
(100 %)
2 diff
(99.8 %id)
TI_57217655   .a 87 to 788 35 to 734       700/734
(95 %)
8 diff
(99.0 %id)
BQ431537 eye, retinoblastoma .a 88 to 952 5 to 877 T120K N121Q K123A P124W G125P ...     873/881
(99 %)
30 diff
(96.6 %id)
CR607918 fetal brain .a 89 to 955 1 to 867 exact     867/867
(100 %)
0 diff
(100 %id)
AL536706 brain, fetal brain .a 89 to 955 1 to 866 M48X R49X E58X     866/866
(100 %)
2 diff
(99.8 %id)
BM016195 breast, mammary adenocarcinoma, cell line .a 90 to 535 1 to 445   AAA   445/445
(100 %)
1 diff
(99.8 %id)
TI_59394590   .a 90 to 535 90 to 534   AAA   445/445
(100 %)
1 diff
(99.8 %id)
BM723584 eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid .a 90 to 563 1 to 474   fully sequenced,   474/474
(100 %)
3 diff
(99.4 %id)
BI256880 cervical carcinoma cell line, cervix .a 91 to 1004 1 to 911 K105H E106K K108R A110K K111P ...     911/911
(100 %)
12 diff
(98.7 %id)
BF969604 adrenal cortex carcinoma, cell line, adrenal gland .a 93 to 860 1 to 763       763/937
(81 %)
36 diff
(96.2 %id)
BG391915 embryonal carcinoma, cell line, testis .a 93 to 818 1 to 725       725/725
(100 %)
7 diff
(99.1 %id)
CR605743 Neuroblastoma Cot 25-normalized .a 94 to 1099 1 to 1006 exact     1006/1006
(100 %)
0 diff
(100 %id)
CR605849 T cells (Jurkat cell line) Cot10-normalized .a 94 to 1653 1 to 1560 exact     1560/1560
(100 %)
0 diff
(100 %id)
CR625358 fetal liver .a 94 to 1097 1 to 1004 exact     1004/1004
(100 %)
0 diff
(100 %id)
BX353790 Neuroblastoma Cot 25-normalized .a 94 to 991 1 to 896 L69P L167X F174X D188X A190S ...     896/949
(94 %)
25 diff
(97.4 %id)
BX362382   .a 94 to 959 1 to 865 L27P L30X M46X Q51X F53X ...     865/865
(100 %)
19 diff
(97.9 %id)
BG519690 brain, neuroblastoma .a 94 to 547 1 to 453   available from MGC, AAA   453/454
(99 %)
3 diff
(99.4 %id)
CR606972 Placenta Cot 25-normalized .a 95 to 1652 1 to 1558 exact     1558/1558
(100 %)
0 diff
(100 %id)
BX337377 Placenta Cot 25-normalized .a 95 to 695 1 to 600   fully sequenced,   600/600
(100 %)
3 diff
(99.5 %id)
BC008311 Brain, neuroblastoma .a 95 to 535 1 to 441   available from MGC, AAA   441/441
(100 %)
1 diff
(99.8 %id)
BX422401 fetal liver, Liver .a 96 to 503 1 to 408   fully sequenced,   408/408
(100 %)
5 diff
(98.8 %id)
CN272672 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .a 100 to 807 1 to 709       709/709
(100 %)
1 diff
(99.9 %id)
BM903941 eye, retinoblastoma .a 105 to 998 1 to 909 D205X S215V A217G M218Y K219E ...     909/1024
(88 %)
25 diff
(97.6 %id)
BU162080 eye, retinoblastoma .a 106 to 956 1 to 854 R186E H187A D188*     854/947
(90 %)
14 diff
(98.6 %id)
AA639587 colon, colon tumor RER+ .a 107 to 544 438 to 1       438/438
(100 %)
1 diff
(99.8 %id)
F11912 brain, total brain .a 109 to 444 1 to 337       337/337
(100 %)
5 diff
(98.6 %id)
F08607 brain, total brain .a 109 to 418 1 to 310       310/310
(100 %)
4 diff
(98.8 %id)
BG032692 breast, mammary adenocarcinoma, cell line .a 109 to 767 12 to 671       660/671
(98 %)
11 diff
(98.4 %id)
BI850497 breast, mammary adenocarcinoma, cell line .a 109 to 819 1 to 711       711/711
(100 %)
9 diff
(98.8 %id)
AW405434 lymph .a 111 to 330 8 to 227       220/236
(93 %)
7 diff
(97.1 %id)
TI_59391935   .a 111 to 820 89 to 800       712/716
(99 %)
5 diff
(99.4 %id)
M15841   .a 111 to 1125 1 to 1015 exact     1015/1015
(100 %)
0 diff
(100 %id)
BM013987 breast, mammary adenocarcinoma, cell line .a 112 to 820 1 to 711       711/715
(99 %)
5 diff
(99.4 %id)
BM464797 lymph, lymphoma, cell line .a 112 to 1013 1 to 906 F210I K211*     906/1112
(81 %)
12 diff
(99.0 %id)
AA931731 2 pooled tumors (clear cell type), Kidney .a 114 to 536 427 to 1       427/427
(100 %)
26 diff
(94.0 %id)
BE260874 brain, neuroblastoma .a 114 to 544 1 to 430   available from MGC,   430/430
(100 %)
2 diff
(99.6 %id)
R61110 whole brain .a 118 to 529 11 to 430       418/460
(90 %)
17 diff
(96.4 %id)
BM467665 lymph, lymphoma, cell line .a 118 to 1048 39 to 983 K47N R186K V192X R204Q K211*     945/1122
(84 %)
43 diff
(96.2 %id)
AW239402 lung, cell line .a 119 to 617 1 to 500       500/506
(98 %)
14 diff
(97.3 %id)
H08348 whole brain .a 120 to 550 1 to 441     Possibly primed on the genome, locally A rich (24/25 A in genome downstream of last aligned base) 439/446
(98 %)
12 diff
(97.4 %id)
CN272667 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .a 121 to 741 1 to 622       620/622
(99 %)
1 diff
(99.9 %id)
BX332744.
matches multiple genes
Neuroblastoma Cot 25-normalized .a 124 to 1087 963 to 1 exact   also hits gene LOC729200 963/963
(100 %)
8 diff
(99.2 %id)
CR601368 Neuroblastoma Cot 25-normalized .a 131 to 1034 1 to 904 exact     904/904
(100 %)
0 diff
(100 %id)
AL524528 brain, neuroblastoma cells, Neuroblastoma Cot 25-normalized .a 131 to 503 1 to 372   fully sequenced,   372/372
(100 %)
3 diff
(99.2 %id)
AA397378   .a 142 to 555 416 to 2       415/416
(99 %)
5 diff
(98.8 %id)
BI856028 breast, mammary adenocarcinoma, cell line .a 142 to 1003 1 to 861 N196Q D197*     861/861
(100 %)
16 diff
(98.2 %id)
TI_57186507   .a 142 to 1003 53 to 913 N196Q D197*     861/861
(100 %)
16 diff
(98.2 %id)
BU170258 eye, retinoblastoma .a 150 to 1028 1 to 884 N196M D197M Q199R A200L G201E ...     884/901
(98 %)
9 diff
(99.1 %id)
BF542158 hypernephroma, Kidney .a 192 to 809 1 to 619       619/862
(71 %)
19 diff
(97.8 %id)
T65188 whole brain .a 243 to 447 1 to 205     Possibly primed on the genome, locally A rich (24/25 A in genome downstream of last aligned base) 205/205
(100 %)
1 diff
(99.6 %id)
BU741000 eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid .a 269 to 544 289 to 14   fully sequenced, AAA   276/276
(100 %)
0 diff
(100 %id)
AL562361 brain, neuroblastoma cells, Neuroblastoma Cot 25-normalized .a 442 to 1034 593 to 1   fully sequenced,   593/593
(100 %)
1 diff
(99.9 %id)
BX422400 fetal liver, Liver .a 442 to 1097 666 to 2   fully sequenced,   665/666
(99 %)
7 diff
(99.0 %id)
F05954 brain, total brain .a 528 to 786 1 to 259       259/259
(100 %)
2 diff
(99.3 %id)
AA224152   .a 539 to 1067 1 to 532       532/532
(100 %)
6 diff
(98.9 %id)
AU310687 neuroblastoma .a 583 to 1118 546 to 11   fully sequenced, AAA Possibly primed on the genome, locally A rich (24/25 A in genome downstream of last aligned base) 536/536
(100 %)
0 diff
(100 %id)
BX337376 Placenta Cot 25-normalized .a 634 to 1609 1020 to 41   fully sequenced,   898/938
(95 %)
20 diff
(97.9 %id)
BX444345 adult brain, brain .a 694 to 1583 892 to 1   fully sequenced,   892/892
(100 %)
17 diff
(98.1 %id)
BX354597 Neuroblastoma Cot 25-normalized .a 745 to 1067 324 to 1   fully sequenced,   324/324
(100 %)
11 diff
(96.7 %id)
H08349 whole brain .a 1248 to 1682 457 to 14   AAA Possibly primed on the genome, locally A rich (24/25 A in genome downstream of last aligned base) 444/445
(99 %)
13 diff
(97.1 %id)
R61832 whole brain .a 1261 to 1684 443 to 6   tiling clone,   438/496
(88 %)
0 diff
(100 %id)
F09559 brain, total brain .a 1400 to 1682 283 to 1       283/283
(100 %)
0 diff
(100 %id)
T65119 whole brain .a 1445 to 1682 251 to 14   AAA Possibly primed on the genome, locally A rich (24/25 A in genome downstream of last aligned base) 238/238
(100 %)
1 diff
(99.6 %id)
TI_149271796   .a 1452 to 2198 877 to 137   AAA Possibly primed on the genome, locally A rich (24/25 A in genome downstream of last aligned base) 741/947
(78 %)
16 diff
(98.4 %id)
Z41577 brain, total brain .a 1459 to 1682 224 to 1       224/224
(100 %)
0 diff
(100 %id)
BU674643 lung, Primary Lung Epithelial Cells .a 1616 to 2198 601 to 19   tiling clone, AAA Possibly primed on the genome, locally A rich (24/25 A in genome downstream of last aligned base) 583/583
(100 %)
5 diff
(99.2 %id)
AA224340   .a 1769 to 2199 439 to 2   tiling clone,   438/443
(98 %)
0 diff
(100 %id)
N30648 placenta .a 1910 to 2198 291 to 1       291/291
(100 %)
3 diff
(99.0 %id)
Z38877 brain, total brain .a 1959 to 2198 240 to 1       240/240
(100 %)
0 diff
(100 %id)
CB112517 Liver .b 1 to 615 1 to 615   tiling clone,   615/615
(100 %)
1 diff
(99.9 %id)
NM_198220.2   .b 5 to 1585 1 to 1581 exact RefSeq, AAA Possibly primed on the genome, locally A rich (24/25 A in genome downstream of last aligned base) 1581/1581
(100 %)
0 diff
(100 %id)
DA088017 cerebellum .b 6 to 583 2 to 579   capped   578/578
(100 %)
1 diff
(99.9 %id)
BF382886 brain, primitive neuroectoderm .b 35 to 748 1 to 703       701/830
(84 %)
45 diff
(94.6 %id)
BG501450 adenocarcinoma, Prostate .b 37 to 714 1 to 683       683/1084
(63 %)
16 diff
(98.6 %id)
BF672748 muscle (skeletal) .b 38 to 760 1 to 734       734/951
(77 %)
28 diff
(97.1 %id)
BF692865 muscle (skeletal) .b 42 to 775 1 to 744       622/921
(67 %)
64 diff
(93.1 %id)
DN920006   .b 44 to 414 16 to 386       371/386
(96 %)
14 diff
(96.4 %id)
CB962871 Blood vessels - aorta, basilar and artery .b 47 to 659 1 to 619       619/782
(79 %)
13 diff
(98.4 %id)
BM786008 Ascites, stomach .b 48 to 658 1 to 611       611/611
(100 %)
2 diff
(99.7 %id)
BP351328   .b 48 to 466 1 to 419       419/582
(71 %)
2 diff
(99.7 %id)
BG545141 lung .b 49 to 665 41 to 656       616/656
(93 %)
10 diff
(98.5 %id)
CB149952 Liver .b 49 to 440 1 to 391   AAA   391/391
(100 %)
9 diff
(97.7 %id)
DN914668   .b 50 to 440 391 to 1       391/391
(100 %)
2 diff
(99.5 %id)
DN914669   .b 50 to 440 1 to 391       391/391
(100 %)
2 diff
(99.5 %id)
BJ990443 hepatoblastoma .b 50 to 600 1 to 551   fully sequenced,   551/551
(100 %)
0 diff
(100 %id)
DA855677 placenta .b 51 to 614 2 to 564   capped   563/563
(100 %)
1 diff
(99.9 %id)
BF219407 brain, glioblastoma .b 52 to 467 1 to 418       416/593
(70 %)
9 diff
(98.5 %id)
BG529758 embryonal carcinoma, testis .b 52 to 732 1 to 689       689/1101
(62 %)
24 diff
(97.9 %id)
BF126328 Liver .b 54 to 718 1 to 657       655/853
(76 %)
16 diff
(98.2 %id)
CN272674 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .b 55 to 435 1 to 381       381/381
(100 %)
4 diff
(99.0 %id)
DA517841 brain .b 56 to 604 2 to 550   capped   549/549
(100 %)
0 diff
(100 %id)
BG500500 adenocarcinoma, Prostate .b 56 to 861 1 to 810 V180S R181T L182S V183G P184N ...     810/822
(98 %)
20 diff
(97.6 %id)
BG531661 embryonal carcinoma, testis .b 56 to 772 1 to 717       717/718
(99 %)
22 diff
(97.0 %id)
BP213199 cerebrum .b 57 to 632 1 to 576       576/576
(100 %)
0 diff
(100 %id)
BP332072 renal proximal tubule .b 57 to 641 1 to 585       585/585
(100 %)
0 diff
(100 %id)
TI_57185972   .b 58 to 705 53 to 700       648/648
(100 %)
1 diff
(99.9 %id)
BF696774 brain, primitive neuroectoderm .b 59 to 711 1 to 650       646/880
(73 %)
23 diff
(97.4 %id)
BI856120 breast, mammary adenocarcinoma, cell line .b 59 to 705 1 to 647       647/647
(100 %)
1 diff
(99.9 %id)
BG032937 breast, mammary adenocarcinoma, cell line .b 61 to 440 1 to 378   AAA   378/378
(100 %)
2 diff
(99.5 %id)
DB499152 hypothalamus .b 63 to 543 1 to 481       481/481
(100 %)
0 diff
(100 %id)
BE568284 bladder, carcinoma, cell line .b 63 to 740 1 to 665       665/665
(100 %)
18 diff
(97.3 %id)
BG110416 Bone, osteosarcoma, cell line .b 63 to 860 1 to 790 N157K P159T E160R E161R T162D ...     790/962
(82 %)
20 diff
(98.0 %id)
BG532010 embryonal carcinoma, testis .b 63 to 825 1 to 770 K103T K104D E106Q K107R K108T ...     770/772
(99 %)
23 diff
(97.1 %id)
BU942144 mixed (pool of 40 RNAs) .b 63 to 727 1 to 673       671/753
(89 %)
13 diff
(98.3 %id)
BM172014 embryonal carcinoma, testis .b 64 to 599 1 to 535       535/535
(100 %)
7 diff
(98.7 %id)
CN272669 embryonic stem cells, DMSO-treated H9 cellline .b 65 to 466 1 to 402       402/402
(100 %)
3 diff
(99.3 %id)
BU532588 mixed (pool of 40 RNAs) .b 65 to 475 1 to 411       411/415
(99 %)
11 diff
(97.4 %id)
BF103545 embryonal carcinoma, testis .b 66 to 744 1 to 686       640/819
(78 %)
31 diff
(96.3 %id)
BF184468 bone marrow, from chronic myelogenous leukemia .b 66 to 785 1 to 707       705/834
(84 %)
28 diff
(96.7 %id)
BM790538 stomach .b 66 to 735 1 to 670       670/670
(100 %)
0 diff
(100 %id)
DA983616 synovial membrane tissue from rheumatioidarthritis .b 66 to 630 2 to 566   capped   565/565
(100 %)
0 diff
(100 %id)
BE567303 bladder, carcinoma, cell line .b 67 to 765 1 to 694       694/696
(99 %)
21 diff
(97.0 %id)
BG484309 lung .b 67 to 910 1 to 852 F34L G35V H36M V37W V38W ...     852/852
(100 %)
28 diff
(96.8 %id)
BM542720 leiomyosarcoma, uterus .b 67 to 1038 1 to 973 exact     973/983
(98 %)
23 diff
(97.7 %id)
BC036737 Uterus, leiomyosarcoma .b 69 to 1032 24 to 987 exact available from MGC, AAA Possibly primed on the genome, locally A rich (24/25 A in genome downstream of last aligned base) 964/976
(98 %)
6 diff
(99.4 %id)
CR592015 fetal liver .b 69 to 1038 1 to 970 exact     970/970
(100 %)
0 diff
(100 %id)
AL532353 brain, fetal liver, Liver, neuroblastoma cells .b 69 to 1035 1 to 967 Y28X E106K P149X L155F P175X ... fully sequenced,   967/967
(100 %)
6 diff
(99.4 %id)
BG118223 adenocarcinoma, cell line, Liver .b 69 to 853 1 to 790 F34L G35V H36M V37W V38W ...     790/1012
(78 %)
30 diff
(97.1 %id)
BG503715 embryonal carcinoma, testis .b 69 to 588 1 to 535       535/535
(100 %)
23 diff
(95.8 %id)
BG529915 embryonal carcinoma, testis .b 69 to 908 1 to 844 K104N P140A F191Y E193D E195D ...     844/844
(100 %)
30 diff
(96.5 %id)
BG532693 embryonal carcinoma, testis .b 69 to 518 1 to 452       452/452
(100 %)
13 diff
(97.2 %id)
BM470619 leiomyosarcoma, uterus .b 69 to 936 25 to 897 N196K D197*     873/1042
(83 %)
23 diff
(97.8 %id)
BF699425 brain, primitive neuroectoderm .b 70 to 781 1 to 713       713/903
(78 %)
18 diff
(98.1 %id)
CB108432 Liver .b 70 to 440 1 to 370   AAA   370/370
(100 %)
2 diff
(99.5 %id)
BM746197 stomach .b 71 to 528 1 to 458       458/458
(100 %)
2 diff
(99.6 %id)
DB494319 hypothalamus .b 72 to 565 1 to 492       492/492
(100 %)
5 diff
(99.0 %id)
BG530447 embryonal carcinoma, testis .b 74 to 807 1 to 739       739/739
(100 %)
13 diff
(98.3 %id)
BM873845   .b 75 to 440 1 to 367   AAA   367/367
(100 %)
2 diff
(99.5 %id)
BE271868.
matches multiple genes
adenocarcinoma cell line, ovary, Ovary, adenocarcinoma .b 76 to 446 1 to 366   available from MGC, also hits gene FAM129B 366/366
(100 %)
9 diff
(97.6 %id)
BG531271 embryonal carcinoma, testis .b 76 to 801 1 to 727       727/781
(93 %)
13 diff
(98.4 %id)
TI_57242301   .b 76 to 830 27 to 777 F34L G35V H36M V37W V38W ...     751/777
(96 %)
11 diff
(98.6 %id)
CB108442 Liver .b 76 to 440 17 to 381   AAA   365/365
(100 %)
0 diff
(100 %id)
AA482714 alveolar rhabdomyosarcoma .b 79 to 455 381 to 5       377/383
(98 %)
3 diff
(99.3 %id)
AA482739 alveolar rhabdomyosarcoma .b 79 to 449 396 to 25   AAA   372/374
(99 %)
6 diff
(98.4 %id)
AA492196 Prostate .b 79 to 455 1 to 378       378/381
(99 %)
10 diff
(97.4 %id)
CN272668 embryonic stem cells, cell lines H1, H7, andH9 .b 80 to 402 1 to 323       323/323
(100 %)
5 diff
(98.5 %id)
BI917237 brain .b 80 to 830 1 to 747 F34L G35V H36M V37W V38W ...     747/747
(100 %)
5 diff
(99.4 %id)
BF575381 muscle (skeletal) .b 82 to 668 1 to 583       583/858
(67 %)
13 diff
(98.5 %id)
BG613753 embryonal carcinoma, testis .b 82 to 850 1 to 762 N12K N13Q M14Y N15E D16*     762/765
(99 %)
32 diff
(95.9 %id)
BE567893 bladder, carcinoma, cell line .b 84 to 610 1 to 530       530/530
(100 %)
6 diff
(98.9 %id)
BM453785 melanotic melanoma, skin .b 84 to 914 1 to 834 exact     834/878
(94 %)
5 diff
(99.5 %id)
CD521220 pooled .b 85 to 734 1 to 656       656/801
(81 %)
13 diff
(98.4 %id)
N36706 melanocyte .b 86 to 467 1 to 383       383/383
(100 %)
8 diff
(98.0 %id)
BG387647 embryonal carcinoma, cell line, testis .b 86 to 667 1 to 581       581/818
(71 %)
1 diff
(99.9 %id)
BX118869 melanocyte .b 87 to 788 1 to 703       703/703
(100 %)
1 diff
(99.9 %id)
DA511729 brain .b 87 to 638 2 to 553   capped   552/552
(100 %)
0 diff
(100 %id)
CD674830 eye, lens .b 87 to 726 1 to 640       640/640
(100 %)
1 diff
(99.9 %id)
BG501625 embryonal carcinoma, testis .b 87 to 692 1 to 607       607/607
(100 %)
5 diff
(99.2 %id)
BI260703 cervical carcinoma cell line, cervix .b 87 to 731 1 to 645       645/645
(100 %)
3 diff
(99.6 %id)
CD685437 normal nasopharynx .b 88 to 686 21 to 619       599/619
(96 %)
7 diff
(98.9 %id)
BM932045 eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid .b 88 to 440 1 to 355   fully sequenced, AAA   355/355
(100 %)
2 diff
(99.5 %id)
BI917715 brain .b 90 to 766 1 to 677       677/677
(100 %)
2 diff
(99.8 %id)
CF127770 Chondrosarcoma Lung Metastasis cell lines, lung .b 92 to 936 1 to 845 exact     845/845
(100 %)
4 diff
(99.6 %id)
TI_154193448   .b 92 to 1009 51 to 966 exact AAA   916/1008
(90 %)
11 diff
(99.0 %id)
CN272673 embryonic stem cells, DMSO-treated H9 cellline .b 97 to 823 1 to 729 E179G V180S R181T L182S V183G ...     729/732
(99 %)
3 diff
(99.6 %id)
BI834413 pooled pancreas and spleen .b 103 to 830 1 to 731 K108N K109E A110S K111Q T112N ...     731/731
(100 %)
11 diff
(98.5 %id)
TI_57163968   .b 104 to 830 32 to 761 K108N K109E A110S K111Q T112N ...     730/761
(95 %)
17 diff
(97.8 %id)
TI_57243755   .b 104 to 766 44 to 706       663/706
(93 %)
6 diff
(99.2 %id)
BX355098 Neuroblastoma Cot 25-normalized .b 105 to 983 881 to 1 N6I E58A K109X A110X K111T ...     881/988
(89 %)
30 diff
(97.0 %id)
BU171508 melanotic melanoma, skin .b 105 to 947 1 to 850 exact     850/852
(99 %)
11 diff
(98.8 %id)
CA867642 Pancreas, Purified pancreatic islet .b 105 to 581 1 to 477       477/477
(100 %)
3 diff
(99.4 %id)
BM754833 Ascites, stomach .b 105 to 439 10 to 341       332/341
(97 %)
9 diff
(97.4 %id)
BG179059 adenocarcinoma, cell line, Prostate .b 109 to 751 1 to 636       636/898
(70 %)
10 diff
(98.9 %id)
BX447922.
matches multiple genes
fetal liver, Liver .b 111 to 1000 894 to 1 N6X M14X Q33X M48X R49X ...   also hits gene LOC729200 892/894
(99 %)
21 diff
(97.7 %id)
AW873615 pooled .b 115 to 728 1 to 614     Submitted on the opposite strand 614/614
(100 %)
11 diff
(98.3 %id)
AW935108 denis_drash .b 119 to 579 526 to 65     Submitted on the opposite strand 462/526
(87 %)
6 diff
(98.9 %id)
AA937145 2 pooled tumors (clear cell type), Kidney .b 119 to 444 326 to 1       326/326
(100 %)
0 diff
(100 %id)
BX392336 Neuroblastoma Cot 25-normalized .b 120 to 1008 890 to 1 D2*     890/890
(100 %)
23 diff
(97.5 %id)
CB107187 Liver .b 131 to 440 1 to 310   AAA   310/310
(100 %)
0 diff
(100 %id)
TI_1948090070.
matches multiple genes
  .b 140 to 817 131 to 809     also hits gene LOC729200 679/1379
(49 %)
8 diff
(99.5 %id)
TI_1948090191   .b 140 to 408 130 to 398   fully sequenced, AAA   269/296
(90 %)
6 diff
(98.0 %id)
TI_1948090324   .b 140 to 530 130 to 520       391/418
(93 %)
6 diff
(98.6 %id)
TI_1948090452   .b 140 to 815 129 to 814       684/1413
(48 %)
34 diff
(97.6 %id)
AB451234   .b 141 to 818 1 to 678 V54A     678/678
(100 %)
1 diff
(99.9 %id)
AB451359   .b 141 to 815 1 to 675       675/675
(100 %)
1 diff
(99.9 %id)
CV030808 mixed .b 141 to 636 1 to 497       497/497
(100 %)
6 diff
(98.8 %id)
BM799655 eye, retinoblastoma .b 177 to 1028 1 to 855       855/855
(100 %)
7 diff
(99.2 %id)
DA076114 cerebellum .b 180 to 737 2 to 559   capped   558/558
(100 %)
1 diff
(99.9 %id)
AA327739   .b 189 to 450 1 to 263       263/263
(100 %)
2 diff
(99.3 %id)
BX374211   .b 194 to 961 839 to 69       771/890
(86 %)
16 diff
(98.3 %id)
T40439.
matches multiple genes
lung .b 201 to 351 151 to 1     also hits gene LOC729200 151/153
(98 %)
5 diff
(96.8 %id)
CR625592 fetal brain .b 204 to 1198 1 to 995       995/995
(100 %)
0 diff
(100 %id)
TI_154123237   .b 204 to 1021 896 to 88   AAA Possibly primed on the genome, locally A rich (24/25 A in genome downstream of last aligned base) 809/968
(83 %)
14 diff
(98.6 %id)
AA279682 germinal center B cell .b 209 to 695 1 to 483   fully sequenced, Possibly primed on the genome, locally A rich (24/25 A in genome downstream of last aligned base) 483/483
(100 %)
4 diff
(99.2 %id)
BE620747 large cell carcinoma, undifferentiated, lung .b 216 to 939 759 to 24       736/926
(79 %)
32 diff
(96.6 %id)
AL537260.
matches multiple genes
brain, fetal brain .b 218 to 1195 14 to 991     also hits gene LOC729200 978/994
(98 %)
14 diff
(98.6 %id)
BU601411 mixed (pool of 40 RNAs) .b 241 to 1027 1 to 800       800/806
(99 %)
29 diff
(96.5 %id)
BM785437 Ascites, stomach .b 248 to 910 1 to 663       663/663
(100 %)
0 diff
(100 %id)
BM764903 Ascites, stomach .b 248 to 908 1 to 661       661/661
(100 %)
0 diff
(100 %id)
BM545702 ovary (pool of 3) .b 251 to 1027 111 to 894       784/1115
(70 %)
23 diff
(98.0 %id)
BX435092 brain, fetal brain .b 253 to 1031 780 to 1       780/841
(92 %)
26 diff
(97.0 %id)
AW842789 colon_normal .b 265 to 578 313 to 1       313/313
(100 %)
2 diff
(99.4 %id)
AW843057 colon_normal .b 265 to 578 312 to 2       311/312
(99 %)
3 diff
(99.1 %id)
BX344647   .b 270 to 996 730 to 1       730/730
(100 %)
16 diff
(97.9 %id)
GD147705   .b 275 to 449 1 to 175   AAA   175/176
(99 %)
7 diff
(96.1 %id)
BG153168 head/neck, nasopharyngeal carcinoma .b 275 to 443 71 to 239       169/242
(69 %)
7 diff
(97.2 %id)
BG272295 head/neck, nasopharyngeal carcinoma .b 275 to 443 170 to 2       169/195
(86 %)
0 diff
(100 %id)
BX462461 T cells (Jurkat cell line) .b 276 to 980 1 to 705       705/705
(100 %)
2 diff
(99.8 %id)
BX435986 T cells (Jurkat cell line) .b 282 to 1030 749 to 1       749/753
(99 %)
13 diff
(98.3 %id)
TI_149276507   .b 286 to 797 51 to 563     Submitted on the opposite strand 513/952
(53 %)
7 diff
(99.3 %id)
TI_149282412   .b 286 to 1022 53 to 790     Submitted on the opposite strand 738/1262
(58 %)
16 diff
(98.8 %id)
CB853991 lung, Primary Lung Epithelial Cells .b 286 to 797 9 to 521     Submitted on the opposite strand 513/529
(96 %)
7 diff
(98.7 %id)
CB854506 lung, Primary Lung Epithelial Cells .b 286 to 918 9 to 642     Submitted on the opposite strand 634/642
(98 %)
6 diff
(99.1 %id)
BU674881 lung, Primary Lung Epithelial Cells .b 291 to 970 14 to 693     Submitted on the opposite strand 680/680
(100 %)
4 diff
(99.5 %id)
CB162969 Liver .b 295 to 719 47 to 471       425/471
(90 %)
7 diff
(98.6 %id)
AI693276 carcinoid, lung .b 297 to 1024 10 to 738     Submitted on the opposite strand 729/738
(98 %)
17 diff
(97.7 %id)
TI_149307267   .b 299 to 1032 824 to 91   AAA Possibly primed on the genome, locally A rich (24/25 A in genome downstream of last aligned base) 734/983
(74 %)
10 diff
(99.0 %id)
TI_149272084   .b 301 to 1023 808 to 88   AAA Possibly primed on the genome, locally A rich (24/25 A in genome downstream of last aligned base) 721/950
(75 %)
8 diff
(99.2 %id)
DN920007   .b 303 to 442 143 to 3       141/143
(98 %)
1 diff
(99.4 %id)
BE926368 breast .b 306 to 584 1 to 277       277/277
(100 %)
8 diff
(97.2 %id)
BQ014214 Chondrosarcoma, Left Pubic Bone .b 313 to 1032 737 to 19   AAA Possibly primed on the genome, locally A rich (24/25 A in genome downstream of last aligned base) 719/721
(99 %)
3 diff
(99.6 %id)
BU942643 mixed (pool of 40 RNAs) .b 315 to 1022 1 to 712   AAA   712/795
(89 %)
21 diff
(97.4 %id)
FN151778 breast carcinoma .b 328 to 419 93 to 3     Submitted on the opposite strand 91/95
(95 %)
2 diff
(97.9 %id)
EC484705 Prostate .b 338 to 439 103 to 3       101/103
(98 %)
0 diff
(100 %id)
AL532352 brain, fetal liver, Liver, neuroblastoma cells .b 347 to 958 650 to 40   fully sequenced,   611/650
(94 %)
12 diff
(98.2 %id)
TI_1948090192   .b 347 to 817 595 to 125   fully sequenced,   471/498
(94 %)
2 diff
(99.6 %id)
BM685069 eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid .b 347 to 449 116 to 14   fully sequenced, AAA   103/103
(100 %)
0 diff
(100 %id)
BU674835 lung, Primary Lung Epithelial Cells .b 351 to 1023 690 to 19   AAA Possibly primed on the genome, locally A rich (24/25 A in genome downstream of last aligned base) 672/672
(100 %)
3 diff
(99.6 %id)
TI_154057013   .b 375 to 1032 737 to 81   AAA Possibly primed on the genome, locally A rich (24/25 A in genome downstream of last aligned base) 657/797
(82 %)
18 diff
(97.8 %id)
AW369998 breast .b 376 to 889 14 to 527       514/541
(95 %)
10 diff
(98.2 %id)
BF091372 testis_normal .b 376 to 797 432 to 12       421/452
(93 %)
7 diff
(98.5 %id)
N44806 melanocyte .b 377 to 880 11 to 519       509/520
(97 %)
15 diff
(97.2 %id)
BE964774 large cell carcinoma, undifferentiated, lung .b 377 to 1023 666 to 17   AAA Possibly primed on the genome, locally A rich (24/25 A in genome downstream of last aligned base) 650/669
(97 %)
30 diff
(95.6 %id)
BU686761 lung, Primary Lung Epithelial Cells .b 377 to 1032 674 to 19   AAA Possibly primed on the genome, locally A rich (24/25 A in genome downstream of last aligned base) 656/658
(99 %)
4 diff
(99.4 %id)
AW027114 thymus, pooled .b 379 to 1022 667 to 23   AAA Possibly primed on the genome, locally A rich (24/25 A in genome downstream of last aligned base) 645/723
(89 %)
35 diff
(95.2 %id)
TI_149310763   .b 393 to 1205 900 to 93   AAA Possibly primed on the genome, locally A rich (24/25 A in genome downstream of last aligned base) 808/984
(82 %)
9 diff
(99.1 %id)
TI_149271231   .b 396 to 1032 750 to 114   AAA Possibly primed on the genome, locally A rich (24/25 A in genome downstream of last aligned base) 637/984
(64 %)
7 diff
(99.3 %id)
AA876340 2 pooled tumors (clear cell type), Kidney .b 402 to 1029 625 to 4       622/625
(99 %)
14 diff
(97.8 %id)
ES312207 frontal balding hair, skin .b 403 to 583 1 to 180       180/180
(100 %)
1 diff
(99.5 %id)
BM849557 stomach .b 404 to 815 1 to 412       412/412
(100 %)
0 diff
(100 %id)
BF334480 colon .b 408 to 808 13 to 416       404/416
(97 %)
6 diff
(98.6 %id)
BG282795 adenocarcinoma, cell line, Prostate .b 413 to 1032 1 to 620   AAA Possibly primed on the genome, locally A rich (24/25 A in genome downstream of last aligned base) 620/620
(100 %)
2 diff
(99.7 %id)
AI830903 lung, squamous cell carcinoma, poorlydifferentiated (4 pooled tumors, including primary andmetastatic) .b 414 to 1024 615 to 7       609/615
(99 %)
6 diff
(99.1 %id)
AA172288   .b 416 to 719 1 to 304   fully sequenced,   304/304
(100 %)
0 diff
(100 %id)
AA635118 lung, lung carcinoma .b 417 to 1030 1 to 608       608/608
(100 %)
20 diff
(96.8 %id)
BE220702 malignant melanoma, metastatic to lymphnode, skin .b 418 to 1024 610 to 4       607/610
(99 %)
5 diff
(99.2 %id)
BQ429653 testis .b 421 to 1092 1 to 687       687/890
(77 %)
46 diff
(94.9 %id)
BQ429734 testis .b 421 to 1038 1 to 628       628/881
(71 %)
25 diff
(97.2 %id)
AA521249 germinal center B cell .b 426 to 1024 610 to 9       602/610
(98 %)
4 diff
(99.4 %id)
N72051 liver and spleen .b 427 to 660 1 to 236       236/240
(98 %)
4 diff
(98.4 %id)
BM737970 Ascites, stomach .b 428 to 665 1 to 234       234/234
(100 %)
6 diff
(97.5 %id)
TI_149308235   .b 438 to 1032 683 to 89   AAA Possibly primed on the genome, locally A rich (24/25 A in genome downstream of last aligned base) 595/962
(61 %)
3 diff
(99.7 %id)
BU687012 lung, Primary Lung Epithelial Cells .b 438 to 1032 613 to 19   AAA Possibly primed on the genome, locally A rich (24/25 A in genome downstream of last aligned base) 595/609
(97 %)
3 diff
(99.6 %id)
AI953991 normal epithelium, ovary .b 441 to 1032 603 to 15   AAA Possibly primed on the genome, locally A rich (24/25 A in genome downstream of last aligned base) 589/589
(100 %)
5 diff
(99.2 %id)
AW173291 pooled .b 448 to 1024 579 to 3       577/579
(99 %)
0 diff
(100 %id)
AA165066   .b 450 to 961 1 to 512       512/512
(100 %)
0 diff
(100 %id)
D55186   .b 454 to 826 1 to 367       367/367
(100 %)
7 diff
(98.1 %id)
TI_151782636   .b 456 to 1180 79 to 787   AAA   707/845
(83 %)
105 diff
(87.6 %id)
BM997308 lung, Metastatic Chondrosarcoma .b 459 to 1013 582 to 29   AAA   554/564
(98 %)
0 diff
(100 %id)
BE881678 large cell carcinoma, undifferentiated, lung .b 462 to 1023 1 to 562   AAA Possibly primed on the genome, locally A rich (24/25 A in genome downstream of last aligned base) 562/562
(100 %)
0 diff
(100 %id)
BU674295 lung, Primary Lung Epithelial Cells .b 478 to 1032 573 to 19   AAA Possibly primed on the genome, locally A rich (24/25 A in genome downstream of last aligned base) 555/555
(100 %)
1 diff
(99.9 %id)
AI707631 aorta .b 482 to 1033 552 to 3       550/552
(99 %)
5 diff
(99.1 %id)
AI475469 pooled .b 483 to 1032 560 to 12   AAA Possibly primed on the genome, locally A rich (24/25 A in genome downstream of last aligned base) 549/549
(100 %)
6 diff
(99.0 %id)
AI422417 brain, glioblastoma (pooled) .b 492 to 1032 532 to 1       537/532
(100 %)
16 diff
(97.0 %id)
AI784530 uterus .b 499 to 1032 548 to 16   AAA Possibly primed on the genome, locally A rich (24/25 A in genome downstream of last aligned base) 533/533
(100 %)
14 diff
(97.4 %id)
AW088419 ovary, tumor, 5 pooled (see description) .b 506 to 1032 525 to 1       525/532
(98 %)
7 diff
(98.7 %id)
CB161641 Liver .b 509 to 1024 524 to 9     Submitted on the opposite strand 516/524
(98 %)
0 diff
(100 %id)
AA824505 germinal center B cell .b 511 to 1032 537 to 19   AAA Possibly primed on the genome, locally A rich (24/25 A in genome downstream of last aligned base) 519/558
(93 %)
16 diff
(97.2 %id)
AI283560 pooled .b 512 to 1023 509 to 1       509/519
(98 %)
12 diff
(97.7 %id)
AI393488 pooled .b 512 to 1029 520 to 4       515/542
(95 %)
8 diff
(98.6 %id)
AI218975 placenta .b 513 to 1023 531 to 21   AAA Possibly primed on the genome, locally A rich (24/25 A in genome downstream of last aligned base) 511/606
(84 %)
19 diff
(96.9 %id)
FN100640 breast carcinoma .b 516 to 603 1 to 90       90/91
(98 %)
6 diff
(93.5 %id)
AI493395 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .b 517 to 1032 514 to 1       514/560
(91 %)
4 diff
(99.3 %id)
AI148132 brain, glioblastoma (pooled) .b 519 to 1033 517 to 3       515/517
(99 %)
1 diff
(99.9 %id)
AI859780 serous papillary carcinoma, high grade, 2pooled tumors, uterus .b 519 to 1023 504 to 1       504/504
(100 %)
4 diff
(99.3 %id)
AA333987   .b 525 to 812 1 to 290       290/290
(100 %)
4 diff
(98.7 %id)
AA936339 pooled .b 526 to 1033 505 to 1       505/525
(96 %)
5 diff
(99.1 %id)
CA748608 Alveolar Macrophage, lung .b 526 to 1205 695 to 17   AAA Possibly primed on the genome, locally A rich (24/25 A in genome downstream of last aligned base) 679/679
(100 %)
1 diff
(99.9 %id)
AI587314 poorly-differentiated endometrialadenocarcinoma, 2 pooled tumors, uterus .b 527 to 1020 542 to 45   AAA   498/518
(96 %)
9 diff
(98.3 %id)
AW070861 pooled .b 528 to 1023 512 to 19   AAA Possibly primed on the genome, locally A rich (24/25 A in genome downstream of last aligned base) 494/500
(98 %)
20 diff
(96.0 %id)
AA339606 brain .b 533 to 823 1 to 294       294/294
(100 %)
6 diff
(98.0 %id)
AW795292 uterus .b 533 to 869 1 to 335       335/335
(100 %)
6 diff
(98.3 %id)
AI126457   .b 537 to 1029 496 to 4       493/496
(99 %)
0 diff
(100 %id)
AI374644   .b 538 to 1024 492 to 6       487/492
(98 %)
1 diff
(99.8 %id)
BJ990444 hepatoblastoma .b 539 to 983 445 to 1   fully sequenced,   445/445
(100 %)
0 diff
(100 %id)
AW795294 uterus .b 543 to 869 1 to 326       326/326
(100 %)
4 diff
(98.8 %id)
AW795284 uterus .b 545 to 869 1 to 325       325/325
(100 %)
3 diff
(99.1 %id)
AI190342 heart .b 545 to 1033 491 to 3       489/491
(99 %)
1 diff
(99.8 %id)
AW022787 cochlea, ear .b 546 to 1024 9 to 487       479/488
(98 %)
7 diff
(98.6 %id)
AW795286 uterus .b 557 to 869 10 to 322       313/322
(97 %)
0 diff
(100 %id)
AI954050 normal epithelium, ovary .b 559 to 1032 472 to 1       472/472
(100 %)
2 diff
(99.6 %id)
AI884607 anaplastic oligodendroglioma, brain .b 562 to 1032 471 to 1       471/471
(100 %)
0 diff
(100 %id)
AW243726 serous papillary carcinoma, high grade, 2pooled tumors, uterus .b 562 to 1032 472 to 1       472/508
(92 %)
14 diff
(97.3 %id)
AA256292 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .b 565 to 1023 467 to 1       465/467
(99 %)
11 diff
(97.7 %id)
AI147287 brain, glioblastoma (pooled) .b 568 to 1033 467 to 3       465/484
(96 %)
4 diff
(99.2 %id)
AI424245 Prostate .b 568 to 1027 465 to 6       460/568
(80 %)
2 diff
(99.7 %id)
AW070395 pooled .b 568 to 1032 487 to 23   AAA Possibly primed on the genome, locally A rich (24/25 A in genome downstream of last aligned base) 465/465
(100 %)
14 diff
(97.0 %id)
AW117316 pooled .b 569 to 1023 455 to 1       455/528
(86 %)
9 diff
(98.3 %id)
AW007098 colon .b 570 to 1033 465 to 3       463/465
(99 %)
0 diff
(100 %id)
AA722224 pineal gland .b 572 to 1021 449 to 1       449/519
(86 %)
27 diff
(94.8 %id)
CN272676 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .b 575 to 986 1 to 411       411/411
(100 %)
6 diff
(98.6 %id)
AW392070 stomach .b 577 to 835 52 to 314       263/328
(80 %)
16 diff
(95.2 %id)
BF379056 uterus .b 580 to 968 49 to 437       389/439
(88 %)
8 diff
(98.2 %id)
N24725 melanocyte .b 581 to 1023 447 to 1       447/447
(100 %)
4 diff
(99.2 %id)
AA281241 germinal center B cell .b 583 to 1024 443 to 2       442/447
(98 %)
0 diff
(100 %id)
DB553919 hypothalamus .b 590 to 1033 1 to 437     Submitted on the opposite strand 437/439
(99 %)
25 diff
(94.4 %id)
BU689031 lung .b 590 to 1205 632 to 17   AAA Possibly primed on the genome, locally A rich (24/25 A in genome downstream of last aligned base) 616/616
(100 %)
0 diff
(100 %id)
BU509716 leiomyosarcoma, uterus .b 593 to 1204 1 to 625       625/974
(64 %)
26 diff
(97.4 %id)
DB507292 testis .b 594 to 1023 1 to 429     Submitted on the opposite strand 429/429
(100 %)
3 diff
(99.4 %id)
H00285 placenta .b 598 to 964 1 to 380       380/417
(91 %)
17 diff
(96.0 %id)
CA867359 Pancreas, Purified pancreatic islet .b 612 to 1204 596 to 4       593/596
(99 %)
0 diff
(100 %id)
BM772256 myeloma .b 612 to 1230 1 to 619   tiling clone,   619/619
(100 %)
0 diff
(100 %id)
BF478330 sciatic nerve .b 615 to 1023 425 to 17   AAA Possibly primed on the genome, locally A rich (24/25 A in genome downstream of last aligned base) 409/409
(100 %)
4 diff
(99.1 %id)
AI283364 ovary, tumor, 5 pooled (see description) .b 616 to 1023 422 to 15   AAA Possibly primed on the genome, locally A rich (24/25 A in genome downstream of last aligned base) 408/408
(100 %)
0 diff
(100 %id)
W95530 heart .b 624 to 1025 1 to 402   fully sequenced,   402/402
(100 %)
3 diff
(99.3 %id)
AI970631 lung, squamous cell carcinoma, poorlydifferentiated (4 pooled tumors, including primary andmetastatic) .b 627 to 1036 428 to 21       408/428
(95 %)
0 diff
(100 %id)
W68821 heart .b 630 to 1027 1 to 401   fully sequenced, AAA   401/401
(100 %)
4 diff
(99.1 %id)
AA279806 germinal center B cell .b 666 to 1023 380 to 23   fully sequenced, AAA Possibly primed on the genome, locally A rich (24/25 A in genome downstream of last aligned base) 358/358
(100 %)
43 diff
(88.0 %id)
AA172036   .b 689 to 1034 346 to 1   fully sequenced,   346/346
(100 %)
2 diff
(99.5 %id)
W68534 heart .b 709 to 1032 325 to 1   fully sequenced,   325/325
(100 %)
1 diff
(99.7 %id)
W95493 heart .b 735 to 1033 303 to 1   fully sequenced,   303/303
(100 %)
0 diff
(100 %id)
H00286 placenta .b 1265 to 1568 311 to 1   tiling clone,   311/311
(100 %)
10 diff
(96.8 %id)
DB442453 testis .c 1 to 427 1 to 428   tiling clone,   428/428
(100 %)
2 diff
(99.6 %id)
BQ226538 melanotic melanoma, skin .c 325 to 1090 8 to 773   tiling clone,   766/773
(99 %)
1 diff
(99.9 %id)
CA430784 cell lines, Chondrosarcoma .c 353 to 1090 755 to 19   tiling clone, AAA Possibly primed on the genome, locally A rich (24/25 A in genome downstream of last aligned base) 737/737
(100 %)
3 diff
(99.6 %id)
CN481783 eye .d 1 to 617 1 to 617   tiling clone,   617/617
(100 %)
0 diff
(100 %id)
AW891690 nervous_tumor .d 600 to 743 151 to 8   tiling clone,   144/163
(88 %)
0 diff
(100 %id)
CD722275 eye, lacrimal gland .d 635 to 1234 1 to 600   tiling clone,   600/600
(100 %)
0 diff
(100 %id)
AW389985 stomach .d 934 to 1183 29 to 276       248/276
(89 %)
6 diff
(97.9 %id)
AI358746 lymph node, lymphoma, follicular mixed small and largecell .d 1094 to 1481 410 to 23   AAA Possibly primed on the genome, locally A rich (24/25 A in genome downstream of last aligned base) 388/388
(100 %)
1 diff
(99.8 %id)
BQ438841 embryonal carcinoma, cell line, testis .d 1101 to 1482 30 to 411       382/462
(82 %)
4 diff
(99.2 %id)
AA873802 2 pooled tumors (clear cell type), Kidney .d 1107 to 1580 470 to 1       470/489
(96 %)
36 diff
(92.7 %id)
AJ714175 bone marrow .d 1117 to 1481 15 to 376   AAA Possibly primed on the genome, locally A rich (24/25 A in genome downstream of last aligned base) 362/376
(96 %)
6 diff
(98.5 %id)
BE675417 B-cell, chronic lymphotic leukemia .d 1120 to 1482 366 to 4       363/366
(99 %)
0 diff
(100 %id)
AA741254 germinal center B cell .d 1123 to 1604 477 to 1       477/477
(100 %)
22 diff
(95.4 %id)
ES316357 pool of melanoma cell lines .d 1135 to 1455 36 to 353       318/389
(81 %)
8 diff
(98.0 %id)
AI630551 blood .d 1138 to 1453 1 to 316       316/316
(100 %)
1 diff
(99.7 %id)
AI129642 uterus .d 1146 to 1481 336 to 1       336/336
(100 %)
0 diff
(100 %id)
N52179 multiple sclerosis lesions .d 1149 to 1654 508 to 1       508/508
(100 %)
9 diff
(98.3 %id)
DV462718 cochlea, ear .d 1154 to 1457 304 to 1     Submitted on the opposite strand 304/304
(100 %)
0 diff
(100 %id)
EC511853 Prostate .d 1156 to 1252 1 to 98       98/98
(100 %)
5 diff
(94.9 %id)
F36575 pectoral muscle (after mastectomy) .d 1156 to 1481 1 to 326   AAA Possibly primed on the genome, locally A rich (24/25 A in genome downstream of last aligned base) 326/329
(99 %)
2 diff
(99.4 %id)
F30881 pectoral muscle (after mastectomy) .d 1162 to 1373 1 to 210       210/210
(100 %)
2 diff
(99.1 %id)
AA055460 heart .d 1163 to 1473 311 to 1       311/311
(100 %)
0 diff
(100 %id)
AA507987 Prostate .d 1186 to 1481 9 to 304   AAA Possibly primed on the genome, locally A rich (24/25 A in genome downstream of last aligned base) 296/304
(97 %)
6 diff
(98.1 %id)
N63112 cochlea, ear .d 1196 to 1482 291 to 5       287/291
(98 %)
0 diff
(100 %id)
AW392753 stomach .d 1211 to 1509 310 to 12       299/314
(95 %)
0 diff
(100 %id)
AA256434 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .d 1211 to 1472 268 to 1       268/268
(100 %)
7 diff
(97.4 %id)
DB565360 hypothalamus .d 1215 to 1647 1 to 433   tiling clone, AAA Submitted on the opposite strand 433/433
(100 %)
1 diff
(99.8 %id)
BM689957 eye, Retina Foveal and Macular .d 1225 to 1472 1 to 248   AAA Possibly primed on the genome, locally A rich (24/25 A in genome downstream of last aligned base) 248/248
(100 %)
0 diff
(100 %id)
BG057435 head/neck, nasopharyngeal carcinoma .d 1228 to 1480 49 to 302       254/308
(82 %)
9 diff
(97.1 %id)
AI472906 pooled .d 1231 to 1652 427 to 3       425/431
(98 %)
0 diff
(100 %id)
D20843   .d 1246 to 1473 1 to 228     Submitted on the opposite strand 228/230
(99 %)
1 diff
(99.6 %id)
AI741327 pooled .d 1254 to 2034 790 to 12   tiling clone, AAA Possibly primed on the genome, locally A rich (24/25 A in genome downstream of last aligned base) 779/779
(100 %)
17 diff
(97.9 %id)
BM682124 eye, fetal eye .d 1258 to 1786 547 to 19   AAA Possibly primed on the genome, locally A rich (24/25 A in genome downstream of last aligned base) 529/529
(100 %)
2 diff
(99.7 %id)
AA872132 pooled germ cell tumors .d 1267 to 1473 210 to 4       207/210
(98 %)
0 diff
(100 %id)
AW960209   .d 1284 to 1480 197 to 1     Submitted on the opposite strand 197/340
(57 %)
0 diff
(100 %id)
FN167728 breast carcinoma .d 1287 to 1410 1 to 124       124/124
(100 %)
0 diff
(100 %id)
AA953215 2 pooled tumors (clear cell type), Kidney .d 1290 to 1654 365 to 1       365/365
(100 %)
0 diff
(100 %id)
T29688 synovial membrane .d 1293 to 1481 192 to 4     Submitted on the opposite strand 189/200
(94 %)
0 diff
(100 %id)
N66486 cochlea, ear .d 1320 to 1481 162 to 1       162/162
(100 %)
0 diff
(100 %id)
CN272671 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .d 1329 to 1783 1 to 455       455/455
(100 %)
0 diff
(100 %id)
N59471 multiple sclerosis lesions .d 1335 to 1654 321 to 1       321/321
(100 %)
3 diff
(99.1 %id)
EC530719 Prostate .d 1357 to 1482 129 to 4       126/129
(97 %)
0 diff
(100 %id)
BG577239 breast, mammary adenocarcinoma, cell line .d 1429 to 1481 1 to 53   AAA Possibly primed on the genome, locally A rich (24/25 A in genome downstream of last aligned base) 53/53
(100 %)
0 diff
(100 %id)
BX374186   .d 1450 to 2031 591 to 6       586/898
(65 %)
0 diff
(100 %id)
DB570259 hypothalamus .d 1524 to 2035 1 to 512     Submitted on the opposite strand 512/512
(100 %)
0 diff
(100 %id)
AA772400 parathyroid gland, parathyroid tumor .d 1622 to 2038 419 to 3       417/419
(99 %)
0 diff
(100 %id)
FN129803 breast carcinoma .d 1856 to 1931 1 to 76       76/77
(98 %)
1 diff
(98.8 %id)
BU620271 Cell Line, Chondrosarcoma .e 1 to 665 681 to 19 T24I F25X A26L D27T E29K ... tiling clone, AAA Possibly primed on the genome, locally A rich (24/25 A in genome downstream of last aligned base) 663/663
(100 %)
2 diff
(99.7 %id)
CN272675 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .f 1 to 584 1 to 584 exact tiling clone,   584/584
(100 %)
2 diff
(99.7 %id)
BP225366   .g 1 to 591 1 to 591 exact tiling clone,   591/602
(98 %)
2 diff
(99.7 %id)
AK095316 tongue, tumor tissue .h-u 1 to 4133 2 to 4135 exact tiling clone, available from FLJ,   4135/4135
(100 %)
13 diff
(99.7 %id)
DA442547 tongue, tumor tissue .h-u 1 to 585 2 to 586 exact capped   585/585
(100 %)
3 diff
(99.5 %id)
BE466925 carcinoid, lung .h-u 2139 to 2580 442 to 1   tiling clone,   442/442
(100 %)
0 diff
(100 %id)
BF110678 carcinoid, lung .h-u 2161 to 2584 424 to 1       424/424
(100 %)
2 diff
(99.6 %id)
DB313778 tongue, tumor tissue .h-u 3606 to 4133 529 to 1       529/529
(100 %)
1 diff
(99.9 %id)
BX485788   .i-u 1 to 616 1 to 618   tiling clone,   618/618
(100 %)
3 diff
(99.6 %id)
AA354769   .i-u 583 to 881 1 to 299 N19X E23X T36X tiling clone,   299/299
(100 %)
0 diff
(100 %id)
DR002643 fetal brain .j -11 to 658 1 to 672 exact tiling clone,   672/672
(100 %)
8 diff
(98.9 %id)
AL699674 human skeletal muscle .k 1 to 540 10 to 549 exact tiling clone,   540/540
(100 %)
0 diff
(100 %id)
DW421465 Liver .l 1 to 238 11 to 248 F7L tiling clone, AAA   240/248
(96 %)
9 diff
(96.4 %id)
BU571020 brain, glioblastoma .l 7 to 245 1 to 239 exact AAA   239/239
(100 %)
3 diff
(98.8 %id)
BU960666 mixed (pool of 40 RNAs) .l 23 to 244 1 to 222 exact tiling clone, AAA   222/222
(100 %)
3 diff
(98.7 %id)
AW891902 nervous_tumor Gene SNRPB2, variant not shown              
CN272670 embryonic stem cells, cell lines H1, H7, andH9 Gene SNRPB2, variant not shown       AAA This clone was ignored    
AA742521 pooled germ cell tumors Gene SNRPB2, variant not shown         This clone was ignored    
AI476780 pooled Gene SNRPB2, variant not shown       AAA This clone was ignored    
BF216038 brain, glioblastoma Gene SNRPB2, variant not shown         Suspected internal deletion, this clone was ignored    
BF243280 bone marrow, from acute myelogenous leukemia Gene SNRPB2, variant not shown         Suspected internal deletion, this clone was ignored    
BG504841 embryonal carcinoma, testis Gene SNRPB2, variant not shown         This clone was ignored    
DA958924 Spleen Gene SNRPB2, variant not shown       capped      
DB334128 Spleen Gene SNRPB2, variant not shown              
CB241055 Human Lung Epithelial cells, lung Gene SNRPB2, variant not shown       AAA This clone was ignored    
? Gene Summary Gene on genome mRNA:.a, .b, .c, .d, .e, .f, .g, .h-u, .i-u, .j, .k, .l Alternative mRNAs features, proteins, introns, exons, sequences Expression Tissue Function, regulation, related genes DCI